GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Alzheimer Disease
In brief
This is a randomized, double-blind, placebo-controlled study that assessed the efficacy, safety, and tolerability of 2 dose levels of COR388 in subjects with a clinical diagnosis of mild to moderate Alzheimer's disease (AD) dementia.
Key facts
- Study ID
- NCT03823404
- Run by
- Cortexyme Inc.
- People needed
- 643
- Starts
- 2019-03-28
- Expected to finish
- 2022-01-01
- Last updated by the study team
- 2023-02-23
Who can join
Age: 55 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Banner Alzheimer's Institute — Phoenix, Arizona, United States
- Banner Sun Health — Sun City, Arizona, United States
- ATP Clinical Research, Inc. — Costa Mesa, California, United States
- Alliance Research — Long Beach, California, United States
- Standford University — Palo Alto, California, United States
- CITRIALS — Riverside, California, United States
- CITRIALS — Santa Ana, California, United States
- Syrentis Clinical Research — Santa Ana, California, United States
- Southern California Research LLC — Simi Valley, California, United States
- JEM Research Institute — Atlantis, Florida, United States
- Brain Matters Research — Delray Beach, Florida, United States
- Neuropsychiatric Research Center of Southwest Florida — Fort Myers, Florida, United States
- MD Clinical — Hallandale, Florida, United States
- Indago Research and Health Center, Inc. — Hialeah, Florida, United States
- Alzheimer's Research and Treatment Center — Lake Worth, Florida, United States
- Qtrials, Inc. — Miami, Florida, United States
- Future Care Solutions, LLC — Miami, Florida, United States
- Miami Dade Medical Research Institute — Miami, Florida, United States
- Sensible Healthcare LLC — Ocoee, Florida, United States
- Bioclinica Research — Orlando, Florida, United States
- Anchor Neuroscience — Pensacola, Florida, United States
- Suncoast Neuroscience Associates, Inc. — St. Petersburg, Florida, United States
- Brain Matters Research at the Kane Center — Stuart, Florida, United States
- Stedman Clinical Trials — Tampa, Florida, United States
- Xenoscience, Inc. — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.